Edaravone attenuates doxorubicin-induced oral mucosal injury via modulation of oxidative stress, inflammatory signaling, and the SIRT1/TLR4/NF-kB/ACE2 axis in rats
Mert Zeytinoglu, Aras Erdil, Sefa Çolak, Mustafa Sami Demirsoy, Ali Tuğrul Akin, Necla Değer, Derya Karabulut, Serdar Savaş Gül, Hatice Aygun, Oytun Erbaş · 2025
Read Edaravone attenuates doxorubicin-induced oral mucosal injury via modulation of oxidative stress, inflammatory signaling, and the SIRT1/TLR4/NF-kB/ACE2 axis in rats by Mert Zeytinoglu, Aras Erdil, Sefa Çolak, Mustafa Sami Demirsoy, Ali Tuğrul Akin, Necla Değer, Derya Karabulut, Serdar Savaş Gül, Hatice Aygun, Oytun Erbaş (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12659584.txt.
Description
BackgroundOral mucositis (OM) is a common complication of chemotherapy, particularly with anthracyclines like doxorubicin (DOX), which induce oxidative stress and inflammation. This study investigated the protective effects of edaravone (EDO), a free radical scavenger, against DOX-induced oral mucosal injury.MethodsTwenty-eight male Wistar rats were randomly divided into four groups (n = 7): Control, DOX (18 mg/kg, i.p.
Catalog record
| CREATOR | Mert Zeytinoglu, Aras Erdil, Sefa Çolak, Mustafa Sami Demirsoy, Ali Tuğrul Akin, Necla Değer, Derya Karabulut, Serdar Savaş Gül, Hatice Aygun, Oytun Erbaş |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |